Sage Therapeutics, Inc.

VOYA INVESTMENT MANAGEMENT LLC

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/14/2025

Shares

15,328

Value ($000)

140

Weight

0.0%

2019 Q4 - 2025 Q2 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/14/2025	140	0.0%	15,328	6/30/2025
2025 Q1	5/15/2025	388	0.0%	48,773	3/31/2025
2024 Q4	5/2/2025	228	0.0%	41,955	12/31/2024
2024 Q3	2/7/2025	250	0.0%	34,636	9/30/2024
2024 Q2	2/7/2025	196	0.0%	18,012	6/30/2024
2024 Q1	2/7/2025	326	0.0%	17,421	3/31/2024
2023 Q4	2/7/2025	456	0.0%	21,050	12/31/2023
2023 Q3	2/7/2025	2,014	0.0%	97,869	9/30/2023
2023 Q2	2/7/2025	3,698	0.0%	78,657	6/30/2023
2023 Q1	2/7/2025	832	0.0%	19,839	3/31/2023
2022 Q4	2/7/2025	766	0.0%	20,088	12/31/2022
2022 Q3	2/7/2025	787	0.0%	20,088	9/30/2022
2022 Q2	8/15/2022	2,579	0.0%	79,824	6/30/2022
2022 Q1	5/16/2022	2,170	0.0%	65,541	3/31/2022
2021 Q4	2/14/2022	2,825	0.0%	66,414	12/31/2021
2021 Q3	11/15/2021	367	0.0%	8,290	9/30/2021
2021 Q2	8/16/2021	468	0.0%	8,246	6/30/2021
2021 Q1	5/17/2021	602	0.0%	8,046	3/31/2021
2020 Q4	2/16/2021	722	0.0%	8,341	12/31/2020
2020 Q3	11/16/2020	542	0.0%	8,864	9/30/2020
2020 Q2	8/14/2020	384	0.0%	9,229	6/30/2020
2020 Q1	5/15/2020	525	0.0%	18,266	3/31/2020
2019 Q4	2/14/2020	1,368	0.0%	18,947	12/31/2019